Recent advances in cancer research have focused on improving the delivery and efficacy of Taxol. Nanotechnology-based delivery systems, for example, aim to enhance the drug's targeting ability, reducing side effects and improving therapeutic outcomes. Moreover, ongoing studies are investigating the synergistic effects of combining Taxol with novel agents such as [immunotherapies](#) and [targeted therapies](#).
